Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshoka India Equity Investment Trust Plc Regulatory News (AIE)

Share Price Information for Ashoka India Equity Investment Trust Plc (AIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 268.00
Bid: 267.00
Ask: 268.00
Change: 4.00 (1.52%)
Spread: 1.00 (0.375%)
Open: 268.00
High: 268.00
Low: 268.00
Prev. Close: 264.00
AIE Live PriceLast checked at -
Ashoka India Equity is an Investment Trust

To achieve long-term capital appreciation, mainly through investment in securities listed in India and listed securities of companies with a significant presence in India.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

7 Oct 2022 10:00

RNS Number : 1667C
Ashoka India Equity Investment Tst
07 October 2022
 

Ashoka India Equity (AIE)

07/10/2022

 

Results analysis from Kepler Trust Intelligence

Ashoka India Equity (AIE) has reported its annual results for the year ending 30/06/2022. The trust delivered net asset value (NAV) and share price total returns of 9.6% and 7.7% respectively. Over the same period AIE's benchmark, the MSCI India IMI Index, delivered returns of 7.2% on a total return basis in sterling terms, meaning the trust outperformed by 2.4% on a NAV basis.

These positive results build upon an already impressive track record. Since its inception in July 2018 to the end of the reporting period, AIE delivered NAV and share price total returns of 75.4% and 73.4% respectively, compared to benchmark total returns of 33.9%. Performance has continued to be strong since, with AIE's NAV increasing by 20.6% and its share price by 23.0% from the end of June to 20/09/2022.

Chairman of the board Andrew Watkins said: "The innovative investment options presenting themselves to the company's management teams are only likely to increase in the coming years, thus further enhancing the possibility of capital growth for shareholders over the longer term. It is gratifying from my perspective to be able to reassure shareholders that strong corporate governance and research both continue to play prominent roles when selecting investments for the company's portfolio. We all hope that 2023 will see an easing of hostilities in Europe, restored supply lines, reduced inflationary pressures and lower interest rates. Not much to hope for, surely? If achieved, the signs are already emerging that India's economy will gather strength as the world returns to growth.

Kepler View

Ashoka India Equity (AIE) is one of a small number of trusts on the market today providing investors with dedicated exposure to Indian companies. The management team focus on stock selection, using a proprietary valuation system and a heavy emphasis placed on corporate governance, rather than using top-down, macroeconomic analysis to pick stocks.

AIE also has a unique fee structure, with the managers receiving no annual management fee. Instead, they are compensated by a performance fee, which is paid if the trust outperforms on a NAV basis over three-year periods. Analysts are compensated according to how well their stock picks perform and fees are paid in shares, all of which we believe strongly aligns the interests of investors and the managers.

Performance since the trust's inception in July 2018 has been strong. From inception in July 2018 to 20/09/2022, AIE shares have delivered total returns of 113.5% and NAV total returns of 116.9%. Over the same period, the MSCI India IMI Index, the trust's benchmark index, has delivered total returns of just 75.1%. We think last year's outperformance was even more impressive given the extremely volatile macroeconomic environment.  CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGIBDGRUGDGDR
Date   Source Headline
19th Jul 20234:09 pmRNSIssue of Equity
19th Jul 202312:34 pmRNSNet Asset Value(s)
18th Jul 202311:52 amRNSNet Asset Value(s)
17th Jul 202312:14 pmRNSNet Asset Value(s)
14th Jul 202312:16 pmRNSNet Asset Value(s)
13th Jul 20234:22 pmRNSIssue of Equity
13th Jul 20232:16 pmRNSNet Asset Value(s)
12th Jul 20235:33 pmRNSIssue of Equity
12th Jul 20231:06 pmRNSNet Asset Value(s)
11th Jul 20231:05 pmRNSNet Asset Value(s)
10th Jul 20234:35 pmRNSIssue of Equity
10th Jul 202312:07 pmRNSNet Asset Value(s)
7th Jul 202312:37 pmRNSNet Asset Value(s)
6th Jul 202312:04 pmRNSNet Asset Value(s)
5th Jul 20231:38 pmRNSNet Asset Value(s)
4th Jul 20231:54 pmRNSNet Asset Value(s)
3rd Jul 20233:34 pmRNSNet Asset Value(s)
3rd Jul 20237:00 amRNSTotal Voting Rights
30th Jun 202312:57 pmRNSNet Asset Value(s)
29th Jun 202311:43 amRNSNet Asset Value(s)
28th Jun 20233:15 pmRNSDirector/PDMR Shareholding
28th Jun 202311:45 amRNSNet Asset Value(s)
27th Jun 202312:00 pmRNSNet Asset Value(s)
26th Jun 20231:07 pmRNSNet Asset Value(s)
23rd Jun 202312:49 pmRNSNet Asset Value(s)
23rd Jun 202311:31 amRNSHolding(s) in Company
22nd Jun 202312:44 pmRNSNet Asset Value(s)
21st Jun 202312:01 pmRNSNet Asset Value(s)
20th Jun 20235:05 pmRNSNet Asset Value(s)
19th Jun 20231:56 pmRNSNet Asset Value(s)
16th Jun 20233:35 pmRNSIssue of Equity
16th Jun 20232:06 pmRNSNet Asset Value(s)
15th Jun 20235:01 pmRNSIssue of Equity
15th Jun 20231:48 pmRNSNet Asset Value(s)
14th Jun 202312:42 pmRNSNet Asset Value(s)
13th Jun 202312:17 pmRNSNet Asset Value(s)
12th Jun 202312:27 pmRNSNet Asset Value(s)
9th Jun 20231:30 pmRNSNet Asset Value(s)
8th Jun 20233:58 pmRNSNet Asset Value(s)
7th Jun 20232:06 pmRNSNet Asset Value(s)
6th Jun 202311:55 amRNSNet Asset Value(s)
5th Jun 202310:46 amRNSNet Asset Value(s)
2nd Jun 202311:27 amRNSNet Asset Value(s)
1st Jun 202312:47 pmRNSNet Asset Value(s)
31st May 202311:19 amRNSNet Asset Value(s)
30th May 202311:35 amRNSNet Asset Value(s)
26th May 202312:03 pmRNSNet Asset Value(s)
25th May 202311:11 amRNSNet Asset Value(s)
24th May 202311:27 amRNSNet Asset Value(s)
23rd May 202311:39 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.